Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Net Cash Flow (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Net Cash Flow for 9 consecutive years, with -$7.8 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 376.64% to -$7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45.0 million through Dec 2025, down 27.67% year-over-year, with the annual reading at -$45.0 million for FY2025, 27.67% down from the prior year.
  • Net Cash Flow hit -$7.8 million in Q4 2025 for Inspire Medical Systems, down from $5.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $231.4 million in Q3 2022 to a low of -$144.6 million in Q4 2023.
  • Historically, Net Cash Flow has averaged -$4.3 million across 5 years, with a median of -$2.6 million in 2021.
  • Biggest five-year swings in Net Cash Flow: surged 587.48% in 2022 and later tumbled 1955.24% in 2024.
  • Year by year, Net Cash Flow stood at $4.3 million in 2021, then skyrocketed by 451.98% to $23.6 million in 2022, then crashed by 712.38% to -$144.6 million in 2023, then surged by 101.94% to $2.8 million in 2024, then tumbled by 376.64% to -$7.8 million in 2025.
  • Business Quant data shows Net Cash Flow for INSP at -$7.8 million in Q4 2025, $5.8 million in Q3 2025, and $52.9 million in Q2 2025.